AIMP2 and Parkinson disease: To understand whether this event occurred in a brain-region-specific manner, we monitored the levels of MYBBP1A and AIMP2 protein in the CTX of PD patients, revealing there was an increasing trend of MYBBP1A in the CTX of PD patients (Figure 4B).